Introduction

Cancer diagnosis and treatment create profound psychological distress for patients and their families. The journey from initial symptoms through diagnosis, treatment, and survivorship presents multiple challenges that extend far beyond physical symptoms. Recognition of these psychological aspects has led to the development of psycho-oncology, a specialized field that addresses the emotional and social consequences of cancer.

The emergence of psycho-oncology represents a shift from purely biomedical approaches to cancer care toward more holistic treatment models. This field encompasses research and clinical practice aimed at understanding and treating the psychological aspects of cancer throughout the disease trajectory. The scope includes anxiety and depression management, coping skills training, family support, end-of-life care, and survivorship issues.

Historical perspectives on cancer care often overlook psychological needs. Patients received little information about their diagnosis or prognosis. The paternalistic medical model dominated, with physicians making treatment decisions without substantial patient input. This approach left patients and families struggling with fear, uncertainty, and isolation.

The 1970s marked a turning point in cancer care philosophy. Patient advocacy movements demanded greater transparency in medical communication. Simultaneously, research began documenting the psychological impact of cancer diagnosis and treatment. These developments created momentum for integrating mental health services into cancer care.

Historical Development of Psycho-Oncology

Early Recognition

The formal recognition of psycho-oncology began in the 1970s when researchers started documenting psychological distress in cancer patients. Dr. Jimmie Holland, often considered the founder of psycho-oncology, established the first psychiatric service in an oncology setting at Memorial Sloan Kettering Cancer Center in 1977. This groundbreaking initiative demonstrated that psychological interventions could be successfully integrated into cancer care.

Early research focused on identifying common psychological reactions to cancer diagnosis. Studies revealed that up to 50% of cancer patients experienced clinically relevant levels of anxiety or depression. These findings challenged the prevailing assumption that psychological distress was a normal and unavoidable consequence of cancer that patients should endure.

The establishment of the International Psycho-Oncology Society in 1984 marked a crucial milestone in the field’s development. This organization provided a platform for researchers and clinicians to share knowledge and develop standards of care. The society’s formation reflected growing international recognition of psycho-oncology as a legitimate medical subspecialty.

Evolution of Practice Models

Early psycho-oncology services often operated as separate entities within cancer centers. Mental health professionals worked independently, with limited integration into oncology teams. This model created barriers to communication and coordination of care. Patients frequently viewed psychological services as separate from their medical treatment, leading to poor utilization rates.

The consultation-liaison model emerged as an alternative approach. In this model, mental health professionals worked directly with oncology teams, providing consultation on psychological aspects of care. This integration improved communication between medical and psychological providers. Patients received more coordinated care, and oncology staff gained access to psychological expertise.

Modern psycho-oncology has evolved toward collaborative care models. These approaches embed mental health professionals within oncology teams. Psychological screening becomes routine, similar to other vital signs monitoring. Treatment plans address both medical and psychological needs simultaneously. This integration represents the current standard for quality cancer care.

Theoretical Foundations

Stress and Coping Models

The theoretical foundation of psycho-oncology draws heavily from stress and coping research. Lazarus and Folkman’s stress and coping model provides a framework for understanding patient responses to cancer. This model suggests that individual appraisal of stressors determines emotional and behavioral responses. Cancer represents a major stressor that challenges patients’ coping resources.

Primary appraisal involves patients’ assessment of the threat posed by cancer. Factors influencing this appraisal include cancer stage, prognosis, treatment demands, and personal meaning attributed to the illness. Secondary appraisal focuses on available coping resources. These resources include social support, financial resources, previous coping experiences, and psychological resilience.

The model suggests that interventions should target both appraisal processes and coping resources. Cognitive behavioral therapy helps patients develop more adaptive appraisals of their situation. Support groups and family therapy strengthen social resources. Problem-solving therapy enhances coping skills for managing treatment demands.

Psychoneuroimmunology

Emerging research in psychoneuroimmunology provides biological explanations for the relationship between psychological factors and cancer outcomes. This field examines how psychological states influence immune system functioning. Chronic stress and depression can suppress immune responses that help control cancer cell growth.

Studies have documented relationships between psychological distress and inflammatory markers in cancer patients. Elevated cortisol levels associated with chronic stress may promote tumor progression. Conversely, positive psychological interventions appear to enhance immune functioning. These findings provide a biological rationale for psychological interventions in cancer care.

However, the clinical implications of psychoneuroimmunology research remain under investigation. While laboratory studies demonstrate clear relationships between psychological factors and immune functioning, translating these findings into clinical practice requires additional research. The field continues to explore how psychological interventions might influence biological outcomes in cancer patients.

Current Evidence Base

Psychological Interventions and Outcomes

Research has established the effectiveness of various psychological interventions for cancer patients. Cognitive behavioral therapy has demonstrated particular efficacy for treating anxiety and depression in this population. Studies consistently show reductions in psychological distress following CBT interventions. Effect sizes are typically moderate to large, indicating clinically meaningful improvements.

Group-based interventions have also proven effective. Support groups offer patients opportunities to share experiences and learn from others facing similar challenges. Structured group programs that incorporate educational components and coping skills training show particular promise. These interventions address social isolation while building coping resources.

Mindfulness-based interventions have gained popularity in recent years. These approaches teach patients to observe their thoughts and emotions without judgment. Research indicates that mindfulness training can reduce anxiety, depression, and pain in cancer patients. The non-judgmental aspect of mindfulness may be particularly helpful for patients struggling with difficult emotions about their diagnosis.

Table 1: Evidence-Based Psychological Interventions in Cancer Care

Intervention Type	Target Population	Primary Outcomes	Effect Size	Duration
Cognitive Behavioral Therapy	All cancer patients	Anxiety, Depression	Medium to Large	8-16 sessions
Support Groups	Newly diagnosed patients	Social support, Coping	Medium	8-12 weeks
Mindfulness-Based Stress Reduction	Patients with high distress	Anxiety, Pain	Medium	8 weeks
Problem-Solving Therapy	Patients with adjustment issues	Coping skills	Medium	6-8 sessions
Psychoeducation	Patients and families	Knowledge, Anxiety	Small to Medium	1-4 sessions
Expressive Writing	All cancer patients	Emotional processing	Small	3-4 sessions

Quality of Life Improvements

Psychological interventions consistently improve quality-of-life measures. These improvements span multiple domains, including emotional well-being, social functioning, and physical symptoms. Patients who receive psychological support report better overall life satisfaction despite their cancer diagnosis.

The relationship between psychological interventions and quality of life appears to be mediated by improved coping skills. Patients who develop effective coping strategies report better adjustment to their illness. They experience less distress about uncertainty and feel more confident in managing treatment demands.

Long-term follow-up studies suggest that quality-of-life benefits persist beyond the intervention period. Patients who participate in psychological interventions show better emotional functioning than control groups. These sustained benefits support the value of investing in psychological care during cancer treatment.

Applications and Use Cases

Screening and Assessment

Routine psychological screening has become a standard component of quality cancer care. The National Comprehensive Cancer Network recommends distress screening at all clinical encounters. This approach identifies patients who would benefit from psychological intervention before problems become severe.

Various screening tools have been developed for cancer populations. The Distress Thermometer provides a quick assessment of overall distress levels. More detailed instruments like the Hospital Anxiety and Depression Scale offer specific information about anxiety and depression symptoms. These tools help healthcare providers identify patients in need of psychological support.

Implementation of screening programs requires careful attention to workflow integration. Successful programs embed screening into routine clinical processes rather than adding separate steps. Electronic health records can facilitate screening by providing automated reminders and tracking responses over time.

Treatment-Specific Interventions

Different cancer treatments present unique psychological challenges that require tailored interventions. Chemotherapy patients often struggle with anticipatory nausea and anxiety about infusion appointments. Behavioral interventions, such as progressive muscle relaxation, can help manage these symptoms. Cognitive techniques help patients develop more positive associations with treatment.

Surgical patients face anxiety about the procedure and concerns about body image changes. Preoperative counseling can reduce anxiety and improve postoperative outcomes. Support groups specifically for surgical patients address concerns about recovery and adaptation to physical changes.

Radiation therapy presents daily treatment demands that can become overwhelming. Brief counseling interventions help patients develop routines and coping strategies to manage their treatment schedules. Relaxation techniques can be particularly helpful during radiation sessions.

An attending oncologist once shared a memorable moment when a patient brought their emotional support peacock to a chemotherapy appointment. While hospital policy typically restricted animals to certified service dogs, the patient’s obvious attachment to their colorful companion and the bird’s surprisingly calm demeanor led to a temporary exception. The peacock sat quietly through the entire infusion, occasionally preening and drawing smiles from other patients and staff. This unusual situation highlighted how patients find comfort in unexpected sources during difficult treatments, reminding the medical team to remain flexible and compassionate in their approach to patient care.

Family and Caregiver Support

Cancer affects entire family systems, not just patients. Family members often experience their own psychological distress while trying to provide support. Caregiver burden is well-documented, with family caregivers showing rates of anxiety and depression similar to patients.

Family-based interventions address the needs of all family members. These programs provide education about cancer and its treatment while teaching communication and coping skills. Family therapy can help resolve conflicts that arise during treatment and improve overall family functioning.

Caregiver support programs specifically target the needs of family caregivers. These interventions teach stress management techniques and provide respite opportunities. Online support groups have become particularly valuable for caregivers who cannot leave their responsibilities to attend in-person sessions.

Survivorship Care

The growing population of cancer survivors has highlighted the need for long-term psychological support. Survivorship brings unique challenges, including fear of recurrence, late effects of treatment, and difficulty returning to normal activities. These issues often emerge years after treatment completion.

Survivorship care plans increasingly include psychological components. These plans identify potential late effects and provide resources for managing ongoing concerns. Follow-up care includes monitoring for psychological distress and providing appropriate referrals.

Peer support programs have proven particularly valuable for survivors. These programs connect recent survivors with individuals who have successfully navigated similar challenges. Peer mentors provide practical advice and emotional support based on their lived experience.

Comparison with Related Fields

Consultation-Liaison Psychiatry

Psycho-oncology shares similarities with consultation-liaison psychiatry but has evolved distinct characteristics. Both fields address psychological aspects of medical illness and work within medical settings. However, psycho-oncology has developed specialized knowledge about cancer-specific issues that general consultation psychiatry may not address.

The timeline of intervention differs between the two fields. Consultation-liaison psychiatry typically responds to acute psychological crises in hospitalized patients. Psycho-oncology provides ongoing support throughout the cancer trajectory, from diagnosis through survivorship or end-of-life care.

Training requirements also distinguish the fields. Consultation-liaison psychiatrists complete a general psychiatry residency followed by subspecialty training. Psycho-oncology practitioners come from various mental health backgrounds, including psychology, social work, and psychiatry. Many receive specialized training in cancer-related issues through fellowships or continuing education programs.

Palliative Care Psychology

There is overlap between psycho-oncology and palliative care psychology, particularly in end-of-life care. Both fields address suffering and aim to improve the quality of life for patients with serious illnesses. However, psycho-oncology encompasses the entire cancer trajectory while palliative care psychology focuses on advanced illness.

The scope of interventions differs between the fields. Palliative care psychology emphasizes meaning-making, legacy work, and preparation for death. Psycho-oncology includes these elements but also addresses issues like treatment decision-making, body image concerns, and return to work planning.

Integration of services has become increasingly common. Many cancer centers now offer combined psycho-oncology and palliative care programs. This integration ensures continuity of psychological support as patients’ needs change throughout their illness.

Health Psychology

Health psychology provides the broader theoretical framework within which psycho-oncology operates. This field examines psychological factors that influence health and illness across all medical conditions. Psycho-oncology applies health psychology principles specifically to cancer populations.

The research methodologies used in both fields are similar. Both employ randomized controlled trials to evaluate intervention effectiveness and use longitudinal designs to track changes over time. However, psycho-oncology research focuses specifically on cancer-related variables and outcomes.

Clinical applications distinguish the two fields. Health psychology addresses a broad range of medical conditions and health behaviors. Psycho-oncology has developed specialized interventions tailored to the unique aspects of cancer diagnosis and treatment.

Challenges and Limitations

Access and Availability

Despite evidence supporting psychological interventions in cancer care, access remains limited for many patients. Rural areas often lack specialized psycho-oncology services. Patients must travel long distances for care or go without psychological support. This geographic disparity creates inequities in cancer care quality.

Insurance coverage for psychological services varies widely. Some patients face high out-of-pocket costs that make psychological care unaffordable. Prior authorization requirements can delay access to care when patients need immediate support.

Workforce shortages also limit access to psycho-oncology services. The number of trained professionals has not kept pace with the growing number of cancer patients. Many cancer centers struggle to recruit qualified mental health providers with oncology expertise.

Integration Challenges

Integrating psychological services into oncology practice requires substantial organizational change. Medical and mental health providers must learn to work collaboratively. Different professional cultures and communication styles can create barriers to effective teamwork.

Time constraints in oncology practice limit opportunities for psychological intervention. Oncologists have packed schedules that leave little time for addressing psychological concerns. Brief interventions must be developed that fit within existing clinical workflows.

Electronic health record systems often lack adequate functionality for documenting psychological care. Mental health providers may use different documentation standards than medical providers. This fragmentation makes it difficult to track psychological outcomes and coordinate care.

Research Limitations

Much of the research in psycho-oncology has been conducted with relatively homogeneous populations. Study participants are often younger, more educated, and have better access to healthcare than typical cancer patients. This limits the generalizability of research findings to diverse patient populations.

Outcome measurement in psycho-oncology research presents ongoing challenges. Psychological outcomes are subjective and can be influenced by multiple factors beyond the intervention being studied. Standardizing outcome measures across studies remains difficult.

The nature of cancer complicates long-term follow-up in psycho-oncology research. Some patients die during follow-up periods, creating missing data. Others may be too ill to participate in research assessments. These factors can bias study results and limit conclusions about the effectiveness of the intervention.

Cultural and Diversity Considerations

Psycho-oncology interventions have been developed primarily in Western, individualistic cultures. These approaches may not be appropriate for patients from collectivistic cultures that emphasize family decision-making and different expressions of emotion. Culturally adapting interventions requires substantial research and development.

Language barriers further limit access to psycho-oncology services. Many interventions are only available in English, excluding non-English speaking patients. Translation of intervention materials requires attention to cultural nuances beyond mere literal translation.

Religious and spiritual considerations are often overlooked in secular psycho-oncology interventions. Many patients find meaning and coping resources through religious or spiritual practices. Interventions that ignore these resources may be less effective for deeply religious patients.

Future Directions and Recommendations

Technology-Enhanced Interventions

Digital health technologies offer promising opportunities for expanding access to psycho-oncology services. Telemedicine can deliver psychological interventions to patients in rural areas or those unable to travel for appointments. Early research suggests that video-based therapy can be as effective as in-person treatment for many patients.

Mobile health applications provide opportunities for self-directed psychological interventions. These apps can deliver training in coping skills, mood monitoring, and relaxation exercises. However, careful evaluation is needed to ensure that apps provide evidence-based content and adequate security protections.

Virtual reality technology is being explored for managing anxiety and pain in cancer patients. These immersive experiences can provide distraction during medical procedures or teach relaxation skills in engaging formats. While promising, virtual reality interventions require additional research before widespread implementation.

Personalized Medicine Approaches

The movement toward precision medicine in oncology has implications for psycho-oncology as well. Genetic factors may influence individual responses to psychological interventions. Research is beginning to explore how personality traits, coping styles, and genetic markers might guide treatment selection.

Machine learning approaches could help identify patients at the highest risk for psychological distress. These predictive models could trigger early interventions before problems become severe. However, care must be taken to ensure that predictive algorithms do not perpetuate existing healthcare disparities.

Biomarker research may eventually guide the selection of psychological interventions. If specific biological profiles predict response to different interventions, treatment could be tailored accordingly. This represents a long-term goal that requires substantial additional research.

Training and Workforce Development

Expanding the psycho-oncology workforce requires enhanced training opportunities. Fellowship programs in psycho-oncology remain limited, restricting the number of specialists entering the field. Academic medical centers should consider developing additional training programs to meet growing demand.

Continuing education programs can help existing mental health providers develop oncology expertise. These programs should address cancer-specific issues like medical treatment effects, communication with medical teams, and end-of-life care. Online training formats can increase accessibility for providers in remote areas.

Training for oncology professionals should include basic psychological skills. Oncologists and nurses need to recognize psychological distress and make appropriate referrals. Communication skills training can help medical providers address emotional concerns within their scope of practice.

Policy and Healthcare System Changes

Healthcare policy changes could improve access to psycho-oncology services. Insurance coverage requirements for psychological care in cancer patients would reduce financial barriers. Quality metrics that include psychological outcomes could incentivize healthcare systems to invest in these services.

Accreditation standards for cancer centers should include requirements for psychological services. The American College of Surgeons Commission on Cancer has begun including psychosocial care standards in its accreditation requirements. Expanding these requirements could drive broader adoption of psycho-oncology services.

Research funding priorities should include implementation science studies. Understanding how to effectively implement psycho-oncology services in diverse healthcare settings is essential for expanding access. These studies should examine both clinical effectiveness and cost-effectiveness of different implementation strategies.

Key Takeaways

The field of psycho-oncology has evolved from a specialized interest area to an essential component of quality cancer care. Evidence clearly demonstrates that psychological interventions improve outcomes for cancer patients and their families. However, access to these services remains limited due to workforce shortages, insurance barriers, and implementation challenges.

Healthcare systems must prioritize integrating psychological services into routine cancer care. This integration requires organizational commitment, adequate resources, and training for all team members. Technology offers promising solutions for expanding access, but cannot replace the need for skilled mental health professionals.

Future research should focus on personalizing psychological interventions and addressing healthcare disparities. Implementation science studies are particularly needed to guide effective service delivery in diverse settings. Policy changes at institutional and governmental levels can support the expansion of psycho-oncology services.

The ultimate goal is to ensure that all cancer patients have access to appropriate psychological support throughout their cancer journey. This requires continued advocacy, research, and investment in psycho-oncology services. The evidence supporting these services is clear; the challenge now is implementation and expansion.

Conclusion

Psycho-oncology has emerged as a vital component of modern cancer care, addressing the profound psychological impact of cancer diagnosis and treatment. The field has evolved from early recognition of patient distress to sophisticated interventions that demonstrably improve quality of life and treatment outcomes. Evidence-based psychological interventions have proven effective across diverse cancer populations and treatment settings.

The integration of psychological services into oncology practice represents a paradigm shift toward more humanistic, patient-centered care. This approach recognizes that effective cancer treatment must address both physical and emotional aspects of the disease. Healthcare systems that embrace this philosophy provide superior care quality and patient satisfaction.

However, substantial challenges remain in ensuring equitable access to psycho-oncology services. Geographic, financial, and cultural barriers continue to limit availability for many patients. Addressing these challenges requires coordinated efforts from healthcare providers, policymakers, and professional organizations.

The future of psycho-oncology lies in continued innovation and expansion. Technology-enhanced interventions offer opportunities to reach underserved populations. Personalized approaches may improve intervention effectiveness. Most importantly, continued advocacy and education can promote broader adoption of psychological services in cancer care.

The evidence is clear that psychological care should be considered a standard component of cancer treatment rather than an optional service. The challenge for the healthcare community is to translate this evidence into practice, ensuring that all cancer patients have access to the psychological support they need and deserve.

Frequently Asked Questions

Q: What is the difference between psycho-oncology and regular mental health counseling?

A: Psycho-oncology is specialized mental health care specifically designed for cancer patients and their families. Practitioners have training in cancer-related issues like treatment side effects, medical decision-making, and end-of-life concerns. Regular mental health counseling may not address these specific challenges or understand the medical aspects of cancer care.

Q: When should cancer patients seek psychological support?

A: Patients can benefit from psychological support at any point during their cancer journey. Many find it helpful to start early, even before treatment begins, to develop coping strategies. Others may need support later when dealing with treatment side effects, recurrence fears, or survivorship issues. There is no wrong time to seek help.

Q: Does insurance cover psychological interventions?

A: Coverage varies by insurance plan and provider type. Many plans cover psychological services, but patients may face copays, deductibles, or session limits. Some cancer centers include psychological services as part of comprehensive cancer care. Patients should check with their insurance provider and healthcare team about coverage options.

Q: How long do psychological interventions typically last?

A: The duration depends on the type of intervention and individual patient needs. Brief interventions may last 4-6 sessions, while longer-term therapy might continue for several months. Some patients benefit from periodic check-ins throughout their cancer journey rather than continuous treatment.

Q: Can family members participate in psychological interventions?

A: Yes, many psycho-oncology programs include family members and caregivers. Family therapy, support groups, and educational programs are available at many cancer centers. Including family members often improves outcomes for both patients and their loved ones.

Q: What if my oncologist doesn’t offer psychological services?

A: Patients can ask their oncologist for referrals to mental health professionals with cancer experience. Many communities have support groups or counseling services specifically for cancer patients. Online resources and telehealth options are also available for patients who cannot access local services.

Q: Do psychological interventions interfere with medical treatment?

A: No, psychological interventions complement medical treatment and may actually improve treatment outcomes. Research shows that patients who receive psychological support often have better treatment adherence and quality of life. Mental health providers work closely with medical teams to coordinate care.

Q: Are there psychological interventions for children with cancer?

A: Yes, pediatric psycho-oncology addresses the unique needs of children and adolescents with cancer. These interventions are adapted for different developmental stages and may include play therapy, art therapy, and family counseling. Most children’s hospitals have specialized psychosocial teams.

Q: What training do psycho-oncology professionals have?

A: Psycho-oncology professionals come from various backgrounds, including psychology, social work, and psychiatry. Many have specialized training through fellowships, continuing education, or certification programs. Look for providers who have specific experience working with cancer patients.

Q: Can psychological interventions help with physical symptoms like pain or nausea?

A: Yes, psychological interventions can help manage physical symptoms through techniques like relaxation training, cognitive behavioral therapy, and mindfulness. These approaches work alongside medical treatments to provide additional symptom relief and improve overall comfort.

References

American Cancer Society. (2023). Cancer treatment and survivorship facts and figures 2023-2025. Atlanta, GA: American Cancer Society.

Andersen, B. L., DeRubeis, R. J., Berman, B. S., Gruman, J., Champion, V. L., Massie, M. J., … & Rowland, J. H. (2014). Screening, assessment, and care of anxiety and depressive symptoms in adults with cancer: An American Society of Clinical Oncology guideline adaptation. Journal of Clinical Oncology, 32(15), 1605-1619.

Breitbart, W., Rosenfeld, B., Pessin, H., Applebaum, A., Kulikowski, J., & Lichtenthal, W. G. (2015). Meaning-centered group psychotherapy: An effective intervention for improving psychological well-being in patients with advanced cancer. Journal of Clinical Oncology, 33(7), 749-754.

Faller, H., Schuler, M., Richard, M., Heckl, U., Weis, J., & Küffner, R. (2013). Effects of psycho-oncologic interventions on emotional distress and quality of life in adult patients with cancer: Systematic review and meta-analysis. Journal of Clinical Oncology, 31(6), 782-793.

Goerling, U., Faller, H., Hornemann, B., Honold, M., Bergelt, C., Maatouk, I., … & Weis, J. (2020). Information needs in cancer patients across the disease trajectory. A systematic review. Patient Education and Counseling, 103(12), 2615-2623.

Holland, J. C., & Alici, Y. (2010). Management of distress in cancer patients. Journal of Supportive Oncology, 8(1), 4-12.

Institute of Medicine. (2008). Cancer care for the whole patient: Meeting psychosocial health needs. Washington, DC: The National Academies Press.

Jacobsen, P. B., & Wagner, L. I. (2012). A new quality standard: The integration of psychosocial care into routine cancer care. Journal of Clinical Oncology, 30(11), 1154-1159.

Li, M., Fitzgerald, P., & Rodin, G. (2012). Evidence-based treatment of depression in patients with cancer. Journal of Clinical Oncology, 30(11), 1187-1196.

Mitchell, A. J., Chan, M., Bhatti, H., Halton, M., Grassi, L., Johansen, C., & Meader, N. (2011). Prevalence of depression, anxiety, and adjustment disorder in oncological, hematological, and palliative-care settings: A meta-analysis of 94 interview-based studies. The Lancet Oncology, 12(2), 160-174.

National Comprehensive Cancer Network. (2023). NCCN clinical practice guidelines in oncology: Distress management. Version 2.2023. Plymouth Meeting, PA: National Comprehensive Cancer Network.

Osborn, R. L., Demoncada, A. C., & Feuerstein, M. (2006). Psychosocial interventions for depression, anxiety, and quality of life in cancer survivors: Meta-analyses. International Journal of Psychiatry in Medicine, 36(1), 13-34.

Riba, M. B., Donovan, K. A., Andersen, B., Braun, I., Breitbart, W. S., Brewer, B. W., … & Darlow, S. D. (2019). Distress management, version 3.2019, NCCN clinical practice guidelines in oncology. Journal of the National Comprehensive Cancer Network, 17(10), 1229-1249.

Rodin, G., Lo, C., Rydall, A., Shnall, J., Malfitano, C., Chiu, A., … & Hales, S. (2018). Managing cancer and living meaningfully (CALM): A randomized controlled trial of a psychological intervention for patients with advanced cancer. Journal of Clinical Oncology, 36(23), 2422-2432.

Sharpe, M., Strong, V., Allen, K., Rush, R., Postma, K., Tulloh, A., … & Cull, A. (2004). Major depression in outpatients attending a regional cancer center: Screening and unmet treatment needs. British Journal of Cancer, 90(2), 314-320.

Watson, M., Homewood, J., Haviland, J., & Bliss, J. M. (2005). Influence of psychological response on breast cancer survival: 10-year follow-up of a population-based cohort. European Journal of Cancer, 41(12), 1710-1714.

Zimmermann, T., Heinrichs, N., & Baucom, D. H. (2007). “Does one size fit all?” Moderators in psychosocial interventions for breast cancer patients: A meta-analysis. Annals of Behavioral Medicine, 34(3), 225-239.